Imaging Techniques to Determine Degree of Sarcopenia and Systemic Inflammation in Advanced Renal Cell Carcinoma
- PMID: 37036632
- PMCID: PMC10330545
- DOI: 10.1007/s11934-023-01157-6
Imaging Techniques to Determine Degree of Sarcopenia and Systemic Inflammation in Advanced Renal Cell Carcinoma
Abstract
Purpose of review: The purpose of this review is to provide an up-to-date understanding regarding the literature on sarcopenia and inflammation as prognostic factors in the context of renal cell carcinoma (RCC).
Recent findings: Sarcopenia is increasingly recognized as a prognostic factor in RCC. Emerging literature suggests monitoring quantity of muscle on successive imaging and examining muscle density may be additionally informative. Inflammation has prognostic ability in RCC and is also considered a key contributor to development and progression of both RCC and sarcopenia. Recent studies suggest these two prognostic factors together may provide additional prognostic ability when used in combination. Ongoing developments include quality control regarding sarcopenia research and imaging, improving understanding of muscle loss mechanisms, and enhancing clinical incorporation of sarcopenia via improving imaging analysis practicality (i.e., artificial intelligence) and feasible biomarkers. Sarcopenia and systemic inflammation are complementary prognostic factors for adverse outcomes in patients with RCC. Further study on high-quality sarcopenia assessment standardization and expedited sarcopenia assessment is desired for eventual routine clinical incorporation of these prognostic factors.
Keywords: Body composition; Inflammation; Prognostic factor; Renal cell carcinoma (RCC); Sarcopenia; Skeletal muscle.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Figures
Similar articles
-
Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma.Cancer. 2021 Jun 15;127(12):1974-1983. doi: 10.1002/cncr.33462. Epub 2021 Mar 24. Cancer. 2021. PMID: 33760232
-
Association between sarcopenia based on psoas muscle index and the response to nivolumab in metastatic renal cell carcinoma: A retrospective study.Investig Clin Urol. 2022 Jul;63(4):415-424. doi: 10.4111/icu.20220028. Investig Clin Urol. 2022. PMID: 35796138 Free PMC article.
-
Dorsal Muscle Attenuation May Predict Failure to Respond to Interleukin-2 Therapy in Metastatic Renal Cell Carcinoma.Acad Radiol. 2017 Sep;24(9):1094-1100. doi: 10.1016/j.acra.2017.03.003. Epub 2017 Mar 22. Acad Radiol. 2017. PMID: 28341412
-
Sarcopenia predicts prognosis of patients with renal cell carcinoma: A systematic review and meta-analysis.Int Braz J Urol. 2020 Sep-Oct;46(5):705-715. doi: 10.1590/S1677-5538.IBJU.2019.0636. Int Braz J Urol. 2020. PMID: 32213202 Free PMC article.
-
The role of sarcopenia in treatment-related outcomes in patients with renal cell carcinoma: A systematic review and meta-analysis.Medicine (Baltimore). 2022 Oct 28;101(43):e31332. doi: 10.1097/MD.0000000000031332. Medicine (Baltimore). 2022. PMID: 36316941 Free PMC article.
Cited by
-
Bone mineral density as a prognostic marker in patients with biliary tract cancer undergoing surgery.BJC Rep. 2024 Sep 23;2(1):72. doi: 10.1038/s44276-024-00094-2. eCollection 2024 Dec. BJC Rep. 2024. PMID: 39323978 Free PMC article.
-
Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia Biomarker.Oncologist. 2023 Dec 11;28(12):e1219-e1229. doi: 10.1093/oncolo/oyad218. Oncologist. 2023. PMID: 37540787 Free PMC article.
-
Imaging Cancer-associated Cachexia: Utilizing Clinical Imaging Modalities for Early Diagnosis.Radiol Imaging Cancer. 2025 Jul;7(4):e240291. doi: 10.1148/rycan.240291. Radiol Imaging Cancer. 2025. PMID: 40476859 Free PMC article. Review.
-
Predictive role of preoperative sarcopenia for long-term survival in rectal cancer patients: A meta-analysis.PLoS One. 2024 May 21;19(5):e0303494. doi: 10.1371/journal.pone.0303494. eCollection 2024. PLoS One. 2024. PMID: 38771764 Free PMC article.
References
-
- Best TD, Roeland EJ, Horick NK, Van Seventer EE, El-Jawahri A, Troschel AS, et al. Muscle loss is associated with overall survival in patients with metastatic colorectal cancer independent of tumor mutational status and weight loss. Oncologist [Internet]. 2021;26:e963–70. 10.1002/onco.13774. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials